Quick Takeaways
- Matthew Paul Kowalsky has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $51,171.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Matthew Paul Kowalsky
- Location
- Marblehead, MA
- Summary
- The estimated net worth of Matthew Paul Kowalsky is at least $51,171 dollars as of 13 Feb 2026. Matthew Paul Kowalsky is the Chief Legal Officer of ENANTA PHARMACEUTICALS INC and owns shares of ENANTA PHARMACEUTICALS INC (ENTA) stock worth about $51.2K.
- Signature
- /s/ Matthew Kowalsky
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Matthew Paul Kowalsky and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: ENANTA PHARMACEUTICALS INC ($51,171).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Matthew Paul Kowalsky
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | Chief Legal Officer | $51,171 | 12 Feb 2026 | ||
| SGTX | Sigilon Therapeutics, Inc. | Chief Of Staff And Clo | 11 Aug 2023 |
Insider Transactions Reported by Matthew Paul Kowalsky:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.